Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia.
Attman
Per-Ola
PO
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001384:Azetidines / Q000627:therapeutic use*; D001596:Benzylamines / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D006435:Renal Dialysis / Q000009:adverse effects*; D013917:Thrombin / Q000037:antagonists & inhibitors; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*; D014511:Uremia / Q000150:complications* / Q000628:therapy
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; C109573:melagatran; D013917:Thrombin